Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Ongoing Initiated Jun 24, 2024 (2 years ago)

SinuFrin Decongestant

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Sub-potent Drug

Cause type: Other

Recalls whose stated reason does not fall into the categories above. See the recall's own reason text for the specifics. All other recalls.

What was recalled

SinuFrin Decongestant (oxymetazoline HCl) Nasal Solution Nasal Decongestant, Decongestant Relief for up to 12 Hours, 12 Hour Relief, 0.5 fl oz (15 ml) bottle, Manufactured by NeilMed Pharmaceuticals Inc, 602 Aviation Blvd, Santa Rosa, CA 95403 877-477-8633; NDC 13709-325-01; UPC 7 05928 09001 9.

Affected NDC 13709-0325-01

Compare with the code on your package — it is the most precise check available.

Drug: Oxymetazoline

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Sinufrin Quick Relief Decongestant
Sinufrin
NDC 13709-0325
OXYMETAZOLINE .4 mg/mL Spray
Nasal
Neilmed pharmaceuticals Inc. OTC
Recalling firm
Neilmed Pharmaceuticals Inc
NDC code
13709-325-01
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0569-2024 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm.

Other Oxymetazoline recalls

See all

Other other recalls from 2024

All other recalls
Class II · Moderate risk

Phenazopyridine HCl Tablets USP

Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

Completed Other Winder Laboratories, LLC NDC 75826-114-10 D-0545-2024
Class III · Low risk

Glimepiride Tablets

Misprint on tablet

Ongoing Other Dr. Reddy's Laboratories, Inc. D-0313-2024
Class III · Low risk

Glimepiride Tablets

Misprint on tablet

Ongoing Other Dr. Reddy's Laboratories, Inc. D-0312-2024